Drawing for MODE

USPTO serial 98112146

MODE

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FOSTER, ALEXANDRA M.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with MODE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.1101 K Street N.W.10th FloorWASHINGTON, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disordersACTIVE—
042Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 21, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 25, 2026EXT5SOU EXTENSION 5 FILED—
Jun 25, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 27, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 10, 2025EX4GSOU EXTENSION 4 GRANTED—
Dec 10, 2025EXT4SOU EXTENSION 4 FILED—
Dec 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 24, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 23, 2025EX3GSOU EXTENSION 3 GRANTED—
May 23, 2025EXT3SOU EXTENSION 3 FILED—
May 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 13, 2024EX2GSOU EXTENSION 2 GRANTED—
Dec 12, 2024EXT2SOU EXTENSION 2 FILED—
Dec 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 3, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 2, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 2, 2024EXT1SOU EXTENSION 1 FILED—
Apr 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2024DOCKASSIGNED TO EXAMINER—
Dec 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 29, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 29, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 29, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2023DOCKASSIGNED TO EXAMINER—
Aug 30, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance